{"filing":{"accession_number":"0001193125-26-241840","cik":"0001061983","ticker":"CYTK","company_name":"CYTOKINETICS INC","form":"8-K","filing_date":"2026-05-27","report_date":null,"primary_document":"cytk-20260527.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1061983/000119312526241840/cytk-20260527.htm"},"events":[{"id":8727,"run_id":7663,"accession_number":"0001193125-26-241840","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear Item 5.07 disclosure of shareholder vote results from Cytokinetics' Annual Meeting of Stockholders held on May 27, 2026. The filing reports voting outcomes for four proposals: election of three Class I directors (Kaye, Wierenga, Wysenski), approval of an amendment to the 2015 Employee Stock Purchase Plan, ratification of Ernst \u0026 Young LLP as independent auditor, and an advisory vote on executive compensation. All proposals passed with substantial majorities, making this a material disclosure of governance and shareholder approval outcomes.","company_name":"CYTOKINETICS INC","ticker":"CYTK","filing_date":"2026-05-27","form":"8-K","submitted_at":null,"items":[{"id":1899,"accession_number":"0001193125-26-241840","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear Item 5.07 disclosure of shareholder vote results from Cytokinetics' Annual Meeting of Stockholders held on May 27, 2026. The filing reports voting outcomes for four proposals: election of three Class I directors (Kaye, Wierenga, Wysenski), approval of an amendment to the 2015 Employee Stock Purchase Plan, ratification of Ernst \u0026 Young LLP as independent auditor, and an advisory vote on executive compensation. All proposals passed with substantial majorities, making this a material disclosure of governance and shareholder approval outcomes.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:13:55.268566+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1899,"accession_number":"0001193125-26-241840","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear Item 5.07 disclosure of shareholder vote results from Cytokinetics' Annual Meeting of Stockholders held on May 27, 2026. The filing reports voting outcomes for four proposals: election of three Class I directors (Kaye, Wierenga, Wysenski), approval of an amendment to the 2015 Employee Stock Purchase Plan, ratification of Ernst \u0026 Young LLP as independent auditor, and an advisory vote on executive compensation. All proposals passed with substantial majorities, making this a material disclosure of governance and shareholder approval outcomes.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:13:55.268566+00:00","company_name":"CYTOKINETICS INC","ticker":"CYTK","filing_date":"2026-05-27"}]}